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Abstract
The promoter of the human adenovirus type 2 IVa2 gene, which becomes active only during the late phase of infection, is built largely
from sequences spanning, and downstream of, the sites of initiation of transcription. These sequences comprise an initiator, an intragenic
sequence necessary for efficient transcription from the promoter by RNA polymerase II, and an intragenic binding site for a cellular repressor
of IVa2 transcription. The properties of the latter protein, which is termed IVa2-RF, suggested that it might account for the viral DNA
synthesis-dependent activation of IVa2 transcription during the adenoviral productive cycle. Here we report the results of experiments to
assess the contributions of DNA template concentration and IVa2-RF binding to the activity of the IVa2 promoter using a transient
expression system. When a IVa2-EGFP reporter gene was introduced into HeLa cells, in which IVa2-RF was identified, no EFGP synthesis
could be detected. In contrast, in IVa2-RF-containing cells in which the plasmid carrying the chimeric gene replicated, synthesis of both the
EGFP protein and the IVa2-EGFP mRNA was readily detected. A vector mutation that blocked plasmid replication reduced IVa2 promoter
activity to undetectable levels. In contrast, a IVa2 promoter substitution that impaired binding of IVa2-RF increased IVa2 promoter activity
under all conditions examined. Furthermore, introduction of DNA containing the IV-RF binding site with the chimeric reporter genes
resulted in increased transcription from the IVa2 promoter in the absence of plasmid replication. These properties are consistent with the
hypothesis that the relative concentration of the IVa2 promoter and of the cellular repressor that binds to it governs transcription from this
adenoviral promoter.
© 2003 Elsevier Inc. All rights reserved.
Introduction
The productive cycle of human subgroup C adenoviruses
such as adenovirus type 2 (Ad2) is characterized by strict,
sequential expression of viral genes (see Shenk, 2001). This
program is established primarily by mechanisms that regu-
late transcription by RNA polymerase II. The E1A tran-
scription unit includes an enhancer that is recognized by
cellular proteins alone (Hearing and Shenk, 1983, 1986).
This gene is therefore transcribed efficiently as soon as the
viral genome enters the nucleus at the beginning of the
infectious cycle. During the early phase of infection, alter-
native splicing of E1A pre-mRNA produces two predomi-
nant mRNAs, which encode 243 and 289 amino acid pro-
teins that differ only in the presence of a unique, internal
sequence in the latter (see Shenk, 2001; Shenk and Flint,
1991). The larger E1A protein activates transcription from
all viral early genes via a variety of cellular transcriptional
regulators (see Flint and Shenk, 1997). It is therefore nec-
essary for successful progression beyond the immediate-
early phase of infection under typical conditions of infection
(Berk et al., 1979; Jones and Shenk, 1979; Nevins, 1981).
Both the 243R and the 289R E1A proteins can also stimu-
late transcription from the viral early E2 promoter (E2E) as
a result of their ability to release cellular, sequence-specific
activators of the E2F family from association with hypo-
phosphorylated Rb, a transcriptional repressor (see Nevins,
1992; Shenk and Flint, 1991). Efficient transcription from
the E2E promoter sets the stage for the transition into the
late phase of infection, for the E2 transcription unit encodes
the viral replication proteins (see Flint, 1986; Shenk, 2001).
Early studies established that synthesis of viral late
mRNAs and proteins requires viral DNA synthesis in in-
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fected cells (see Flint, 1986; Shenk, 2001). In fact, initiation
of viral genome replication once E2 proteins have attained
an appropriate intranuclear concentration leads to three dis-
tinct types of transcriptional alteration. In the first place,
three viral promoters (pIX, IVa2, and E2 late) that are silent
during the early phase of infection become active (see Flint,
1986; Shenk, 2001). In addition, transcription of the major
late (ML) transcription unit terminates close to the right end
of the genome (Fraser et al., 1979), rather than at many sites
within a large sequence near the middle of the transcription
unit, the pattern observed prior to viral DNA synthesis
(Akusja¨rvi and Persson, 1981; Iwamoto et al., 1986; Shaw
and Ziff, 1980). The mechanism by which termination of
ML transcription is regulated is not known, but the switch in
termination might be governed by differences in the asso-
ciation with proteins of entering viral DNA molecules and
those produced within the infected cell. Finally, the effi-
ciency of ML transcription increases some 20- to 30-fold
with the transition into the late phase of infection (Shaw and
Ziff, 1980).
Such late phase-specific stimulation of ML transcription
requires promoter sequences located at positions 86 to
96 (DEF1) and positions 113 to 124 (DEF2) of the
ML transcription unit in both in vitro transcription systems
and infected cells (Jansen-Durr et al., 1988; Leong et al.,
1990; Mansour et al., 1986; Mason et al., 1990). These
sequences are recognized by proteins present only in in-
fected cells (Jansen-Durr et al., 1988, 1989; Leong et al.,
1990; Mondesert et al., 1992). The protein termed DefB,
which binds to DEF2, is a dimer of the viral late IVa2
protein (IVa2p), whereas DefA, which binds specifically to
DEF1, contains IVa2p and one or more additional, infected
cell-specific proteins that have not yet been identified (Lutz
and Kedinger, 1996; Tribouley et al., 1994). The IVa2
protein is the only sequence-specific transcriptional activa-
tor encoded within the adenoviral genome, although its
sequences required for DNA binding do not conform to
those of any well-characterized DNA- binding motif (Lutz
and Kedinger, 1996). Stimulation of ML transcription by
the IVa2 protein in infected cells remains to be demon-
strated directly, in part because IVa2p also is responsible for
recognition of the viral DNA packaging signal and therefore
essential for assembly of virus particles (Zhang and Impe-
riale, 2000, 2003). However the observation that the IVa2
protein stimulates ML transcription in a transient expression
assay via the internal promoter sequences listed above (Tri-
bouley et al., 1994) is consistent with such a role. Such
dependence of efficient ML transcription on synthesis of the
IVa2 protein would imply that the crucial step in establish-
ing the late-phase transcriptional program in adenovirus-
infected cells is DNA synthesis-dependent activation of
transcription from the IVa2 promoter.
In previous studies, we identified a cellular protein that
represses IVa2 transcription by binding to an internal se-
quence of the viral promoter (Chen et al., 1994; Lin and
Flint, 2000). The promoter sequence contacted by this re-
pressor, which is currently termed IVa2-RF, lies between,
and is partially superimposed on, both the initiator element
and an internal sequence essential for efficient initiation of
IVa2 transcription (Chen et al., 1994; Lin and Flint, 2000).
Adenovirus infection does not result in reduced activity of
IVa2-RF (Lin and Flint, 2000). We therefore proposed that
the IVa2 promoter becomes active in infected cells only
when viral DNA synthesis increases its concentration above
that at which all copies can be bound by the repressor. Here
we report the results of experiments demonstrating DNA
synthesis-dependent titration of the repressor of IVa2 tran-
scription in a simplified experimental system.
Results and discussion
Replication-competent plasmids containing IVa2-EGFP
reporter genes
To test the hypothesis that the activity of the Ad2 IVa2
promoter is controlled by the relative concentrations of the
cellular repressor of its transcription, IVa2-RF, and the bind-
ing sites for this protein in the IVa2 promoter, the latter
promoter was introduced into a plasmid vector that can
replicate in mammalian cells under appropriate conditions.
This vector contains the SV40 origin of replication, which is
recognized by SV40 large T antigen (LT), the only viral
protein required for replication from this origin (Diffley,
1992; Fanning, 1994). The Ad2 IVa2 promoter, or a mutant
derivative (Rep6) containing a substitution that decreases
the affinity of IVa2-RF for its binding site some five-fold
(Lin and Flint, 2000), was introduced upstream of an EGFP
reporter gene in the SV40-origin containing vector (Fig. 1),
as described under Materials and methods. Sibling vectors
that cannot replicate even in the presence of LT were con-
structed by mutation of the SV40 origin binding for LT,
which is essential for replication from this origin (see De-
Pamphilis, 1993; Fanning, 1994). This mutation inhibited
synthesis of vector DNAs in LT-producing cells as expected
(see Fig. 5B). These origin-lacking vectors also provided
controls for any effects of SV40 LT on the activity of the
adenoviral IVa2 promoters: LT is not only the origin rec-
ognition protein of SV40, but also activates viral late tran-
scription (Brady et al., 1984; Keller and Alwine, 1984) and
can stimulate transcription from many promoters in tran-
sient expression assays (Damania and Alwine, 1996).
The Ad2 IVa2 promoter is inactive in uninfected HeLa
cells
The activity of the IVa2 promoter was first examined in
Hela cells, in which IVa2-RF was identified (Chen et al.,
1994). These cells do not contain coding sequences for
SV40 LT and therefore cannot support replication of the
vectors described in the previous section. The SV40 origin-
containing plasmids were introduced into HeLa cells by the
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calcium phosphate coprecipitation method and EGFP
autofluorescence was examined 24 to 72 h later, as de-
scribed under Materials and methods. The strong, constitu-
tive, human cytomegalovirus immediate-early promoter in
the same vector was introduced into parallel cultures as a
positive control. A significant fraction of the cells that
received the latter plasmid exhibited a strong EGFP signal
(Fig. 2). In contrast, no cells into which the wild-type (wt)
IVa2-EGFP reporter gene was introduced synthesized such
high concentrations of the protein, and only a small number
exhibited much weaker EGFP autofluorescence at any time
examined (Fig. 2). Furthermore, the Rep6 promoter muta-
tion did not increase the number of cells synthesizing EGFP
(data not shown).
Our in vitro analyses of the organization of the IVa2
promoter employed HeLa cell extracts competent for tran-
scription by RNA polymerase II (Kasai et al., 1992; Chen
and Flint, 1992; Chen et al., 1994). Such systems support
quite efficient IVa2 transcription, but only at specific ratios
of extract proteins to template DNA concentrations: as the
concentration of HeLa cell proteins was increased above an
optimal value, the efficiency of IVa2 transcription was ob-
served to decrease sharply (Leong and Flint, 1984), a prop-
erty subsequently attributed to inhibition by IVa2-RF (Chen
et al., 1994). The results described here indicate that the
HeLa cells contain a sufficient concentration of IVa2-RF to
block transcription from even the relatively large number of
IVa2 promoters that is likely to be introduced into individual
cells by DNA-mediated transformation. They are therefore
consistent with one crucial tenet of the repressor titration
hypothesis described in the introduction.
COS-1 cells contain IVa2-RF
Cells of the COS-1 line, which was derived from African
monkey kidney CV1 cells, synthesize large quantities of
SV40 LT constitutively and support DNA synthesis from
the SV40 origin of replication (Gluzman, 1981). To deter-
mine whether these cells were suitable for analysis of the
effects on DNA replication on the activity of the Ad2 IVa2
promoter, we assayed whole-cell extracts prepared from
them for IVa2-RF activity, using the electrophoretic mobil-
ity shift method described under Materials and methods.
When COS-1 cell proteins were incubated with a synthetic,
32P-labeled DNA fragment containing the IVa2-RF binding
site of the IVa2 promoter, a complex of low mobility that
comigrated with a complex formed by HeLa cell proteins
was observed (Fig. 3, lanes 2 and 8). The unlabeled IVa2
DNA sequence effectively blocked formation of both the
HeLa and the COS-1 protein–DNA complexes, but a DNA
fragment containing the Rep6 mutation, which impairs
binding of human IVa2-RF (Lin and Flint, 2000), was a
much less effective competitor (Fig. 3, compare lanes 3–6
to lane 2 and lanes 9–12 to lane 8). These data establish that
Fig. 2. Comparison of the activities of Ad2 IVa2 and HCMV IE promoters
in HeLa cells. Five micrograms of the SV40 origin-containing vectors
carrying the reporter genes were introduced into HeLa cells and the cells
were photographed 48 h later under phase and dark field illumination using
a Nikon Eclipse TE200 fluorescent microscope equipped with a digital
camera. The percentage of EGFP-positive cells, determined in two inde-
pendent experiments, is summarized at the right.
Fig. 1. Organization of Ad2 IVa2-EGFP reporter genes. The segment of the
Ad2 genome containing the IVa2 promoter is illustrated at the top, with
jointed arrows denoting the sites of initiation of ML and IVa2 transcription.
As shown, the IVa2 promoter directs expression of the EGFP reporter gene
(gray) in the plasmids used in these experiments. The sequences required
for transcription from this promoter extend from positions 5 to 31
(Chen and Flint, 1992; Chen et al., 1994). Sequences contacted by IVa2-RF
are indicated by the shaded oval. The IVa2 promoter sequence contacted by
IVa2-RF (Chen et al., 1994) is listed above, and the substitutions present in
the Rep6 promoter are indicated in bold, oblique face. These substitutions
alter the central segment of the IVa2-RF binding site that is not also part of
the initiator or essential, intragenic stimulatory elements (Lin and Flint,
2000). As indicated, this segment of viral DNA was introduced into the
multiple cloning site of pEGFP-1 (Clontech) to construct chimeric IVa2-
EGFP reporter genes. The position of the SV40 origin is indicated.
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simian COS-1 cells contain IVa2-RF activity. Moreover, the
results of experiments in which the formation of the
IVa2-RF complex was examined as a function of extract
protein concentration (data not shown) indicated that the
concentrations of the repressor in HeLa and COS-1 cell
extracts were similar.
Replication-dependent activity of the IVa2 promoter in
COS-1 cells
To investigate the effects of increased intracellular DNA
concentration on control of IVa2 promoter activity by IVa2-
RF, the SV40 origin-containing and -lacking plasmids car-
rying chimeric IVa2-EGFP genes were introduced into
COS-1 cells, and reporter gene expression was examined
initially using EGFP autofluorescence. In contrast to the
results obtained with HeLa cells, a substantial fraction of
COS-1 cells receiving wt IVa2-EGFP in the origin-contain-
ing vector exhibited moderate-to-strong fluorescence (Fig.
4). The exact proportion of such EGFP-synthesizing cells
varied from experiment to experiment (Table 1). Neverthe-
less, efficient synthesis of EGFP required the presence of a
functional origin of replication in the vector: the mutation
that eliminated the origin both substantially reduced the
number of cells in which EGFP could be detected (Table 1)
and the strength of the fluorescent signal in those cells
synthesizing EGFP (Fig. 4). We can therefore conclude that
expression of the chimeric IVa2-EGFP gene in COS-1 cells
is not the result of stimulation of transcription from the
adenoviral promoter by SV40 LT, but rather correlated with
the ability of the vector DNA to replicate.
The activity of the IVa2 promoter carrying the Rep6
substitution was also compared to that of the wild-type. This
mutation reproducibly resulted in synthesis of EGFP in a
slightly higher fraction of cells, but this increase was too
small to be considered significant (Table 1). Because the
Rep6 mutation decreases the affinity with which IVa2-RF
binds to the IVa2 promoter by some five-fold, and increases
the efficiency of IVa2 transcription in vitro, this minimal
effect of the Rep mutation was somewhat unexpected. How-
ever, it seemed possible that the reporter genes reached
sufficiently high concentrations in the period before EGFP
autofluorescence was examined to obscure any difference in
the initial rates of transcription from the wild-type and
mutant promoters. Furthermore, although convenient and
rapid, examination of EGFP autofluorescence does not pro-
vide a quantitative measure of reporter gene expression and
hence promoter activity. For example, the quantities of
EGFP produced in individual cells varied considerably
(e.g., Fig. 4), a parameter that is difficult to quantify, and
ignored in a simple count of cells positive above a particular
(subjective) threshold. Such considerations prompted direct
examination of the synthesis of chimeric IVa2-EGFP
mRNAs in cells containing the wild-type and Rep6 reporter
genes.
Cytoplasmic and nuclear fractions were prepared from
COS-1 cells into which the various vectors had been intro-
duced and RNA was purified from the former fraction as
described under Materials and methods. Chimeric IVa2-
EGFP mRNA was assayed using primer extension from a
primer complementary to a 25-nucleotide sequence within
the EGFP coding sequence. Low-molecular-mass DNA was
isolated from the nuclear fraction of each sample, and the
vector DNA was examined by hybridization to an internal
fragment of the EGFP gene following transfer of the DNA
to nylon membranes, as described under Materials and
methods. The results of one such experiment are shown in
Fig. 3. COS-1 cells contain IVa2-RF. Binding of HeLa or COS-1 cell whole-cell extract proteins to the IVa2 promoter binding site for IVa2-RF was examined
as described under Materials and methods. Binding reactions contained 8 g whole-cell extract proteins, 0.2 ng 32P-labeled DNA, 1 g poly(dI) · poly(dC)
and the molar excess concentrations of unlabeled competitor wild-type (WT), Rep6, or unrelated (NS) DNAs indicated. The position of the specific
IVa2-RF–DNA complex is indicated by the arrow at the right.
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Fig. 5, and data from several such experiments are summa-
rized in Table 2.
The 89-nucleotide-long cDNA product predicted for
primer extension of the chimeric mRNA was detected in
RNA preparations made from COS-I cells into which the
SV40 origin-containing vectors were introduced (Fig. 5A,
lanes 3, 4, 7, and 8). However, no chimeric mRNA was
evident in the corresponding RNA preparations from cells
that had received the origin-lacking plasmids (Fig. 5A, lanes
5, 6, 9, and 10). As illustrated in Fig. 5B, the vector DNAs
were nevertheless present in the nuclei of such cells, al-
though, as expected, at substantially lower concentrations
than those attained by the origin-containing DNAs. These
results therefore confirmed that the activity of the IVa2
promoter is governed by promoter concentration. Further-
more, the results obtained when the activity of the Rep6
mutant promoter was compared to that of the wild-type
established that this property is not merely a result of the
greater ability of the viral promoter to compete for compo-
nents of the cellular transcriptional machinery when its
concentration is increased by plasmid replication. The Rep6
mutation resulted in a significant increase in chimeric
mRNA concentration compared to that observed in cells
containing the wild-type IVa2-EGFP reporter gene (Fig. 5A;
compare lanes 3 and 7 and lanes 4 and 8). In this experi-
ment, the vector containing the mutant promoter accumu-
lated to a slightly higher concentration than its sibling car-
rying the wild-type (Fig. 5B). However, this difference was
far too small to account for the 10-fold difference in the
corresponding chimeric mRNA concentrations determined
by PhosphorImager analysis (Fig. 5A; Table 2).
An internal control plasmid was introduced into COS-1
cells with the IVa2-EGFP-containing vectors in experiments
similar to that shown in Fig. 5. However, we invariably
observed synthesis of concentrations of control mRNAs too
low for reliable quantification, regardless of whether an
RSV-neomycin or an HCMV-luciferase reporter gene was
used. Such poor expression of widely used reporter genes
was presumably a result of the low concentrations of their
promoters, which were introduced into COS-1 cells in non-
replicating plasmids, in the cells that also contained high
concentrations of the IVa2-EGFP reporter genes. To obtain
a quantitative measure of the effects of the Rep6 mutation,
we therefore determined the concentrations of both the
chimeric IVa2-EGFP mRNA and the vector DNA using the
methods described above. In these experiments, only the
Fig. 4. Comparison of the activities of the IVa2 promoter in replicating and nonreplicator vectors. Five micrograms of each of the vectors indicated was
introduced into COS-1 cells and EGFP autofluorescence was examined at 48 h as described in the legend to Fig. 2.
Table 1
Expression of an EGFP reporter gene from wt and mutant IVa2
promoters in the absence and presence of plasmid replication
IVa2 promoter SV40 ori % Cells EGFP positivea
Experiment 1 Experiment 2
wt Ori 2.8 1.7
wt Ori 21.0 12.5
Rep6 Ori 4.5 0.9
Rep6 Ori 23.4 14.2
a Cells containing 15 g of the vectors indicated exhibiting moderate-
to-strong autofluorescence were scored as positive.
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SV40 origin containing vectors were employed, and such
parameters as quantities of DNA were introduced and time
of incubation following DNA introduction were varied. The
data collected in such experiments, one of which is shown
in Fig. 6, were used to calculate ratios of reporter mRNA
concentrations to those of the DNA template. Under all
conditions tested, IVa2-EGFP mRNA synthesis normalized
in this way to template concentration was more efficient
from the Rep6 than from the wild-type IVa2 promoter (Ta-
ble 3). The mutation increased the activity of the IVa2
promoter from three- to nine-fold under the various exper-
imental conditions (Table 3). As the magnitude of this
difference could not be clearly correlated with any particu-
lar experimental parameter, the variability observed is likely
to be due to differences in the efficiencies with which cells
took up DNA and in the rates of plasmid replication in
different experiments. Regardless, the greater efficiency of
reporter gene expression from the Rep6 promoter observed
in every experiment establishes that IVa2-RF represses IVa2
transcription in vivo.
The methods employed in these studies assess the total
concentrations of mRNA or DNA accumulated during the
period in which cells containing the vector DNAs were
incubated. Nevertheless, the patterns of IVa2-EGFP mRNA
concentration per unit of DNA as a function of time are
consistent with the view that the IVa2 promoter becomes
active only above a certain threshold concentration. This
parameter increased more or less continuously when expres-
sion of the EGFP gene was controlled by the Rep6 promoter
(Fig. 6), suggesting that the promoter concentration attained
by the time the analysis began was sufficient to support the
maximal rate of transcription. In contrast, the chimeric
Fig. 5. Analysis of IVa2-EGFP mRNA synthesis and vector DNA concen-
tration in COS-1 cells. (A) Cytoplasmic RNA was purified from COS-1
cells 48 h after introduction of quantities of the vectors indicated and
IVa2-EGFP mRNA was examined by primer extension. The position of the
cDNA synthesized from this mRNA is indicated by the arrow at the right
and the lengths of the 32P-labeled DNA markers run in lanes 1 and 11 are
listed at the left. Lane 2 shows the products of primer extension of
cytoplasmic RNA prepared from COS-1 cells into which no exogenous
DNA was introduced. (B) Vector DNA present in the nuclear fractions
obtained from the samples receiving 15 g vector DNA shown in (A) was
examined by hybridization to a 32P-labeled, internal fragment of the EGFP
coding sequence.
Table 2
Relative chimeric mRNA concentrations
IVa2 promoter SV40 origin Relative (IVa2-EGFP mRNA)a
Expt. 1
15
Expt. 2
7.5
Expt. 3
15 g DNA
wt Ori ND ND 0.03
wt Ori 1.0 1.0 1.0
Rep6 Ori ND ND ND
Rep6 Ori 16.3 5.6 10.1
ND  not detectable.
a mRNA signals are expressed relative to that obtained with the wt
IVa2-EGFP reporter in the SV40 origin-containing vector.
Fig. 6. Accumulation of IVa2-EGFP mRNA and vector DNA in cells
containing the wt and Rep6 IVa2 promoters. COS-1 cells that had received
2.5 g of the SV40 origin-containing vectors carrying wt (A) or Rep6 (B)
IVa2-EGFP genes were harvested after the periods incubated. In this
experiment, time zero was 12 h following addition of the DNA-containing
precipitate. The chimeric reporter mRNA and vector DNA were assayed as
in the experiment shown in Fig. 5. The cDNA (mRNA) and vector DNA
(DNA) PhosphorImager signals were expressed relative to these obtained
for the wt IVa2-EGFP at 24 h and are shown in relative, arbitrary units.
Table 3
Comparison of the activities of the wt and Rep6 IVa2 promoters
Quantify vector
DNA introduced,
g
Time of
incubation, h
(IVa2-EGFP
mRNA)/
(vector DNA)a
Rep6:wt
wt Rep6
15.0 48 23.6 72.7 3.1
15.0 24 11.7 154.0 9.1
7.5 48 10 56.0 5.6
2.5 24 10 35.0 3.5
2.5 12 3.7 227.0 6.2
a Arbitrary units.
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mRNA accumulation as a function of concentration of the
wild-type IVa2-EGFP DNA template increased substan-
tially only during the latest period examined (Fig. 6). This
property indicates that some threshold concentration of the
IVa2 promoter, at which all copies cannot be bound by
IVa2-RF, must be attained to permit transcription from it.
As a further test of the conclusion that the relative con-
centrations of IVa2-RF and the promoter govern IVa2 tran-
scription, we sought to decrease the effective concentration
of the repressor by introduction of its DNA-binding site.
Increasing quantities of the synthetic DNA containing the
IVa2-RF binding site described previously were therefore
introduced into COS-1 cells with a fixed concentration of
the origin-lacking plasmid containing the wild-type IVa2-
EGFP reporter gene. As this plasmid cannot replicate, the
IVa2 promoter was maintained at a fixed concentration as
the concentration of exogenously added IVa2-RF DNA was
increased. Promoter activity was then assessed by examina-
tion of EGFP autofluorescence. As shown in Fig. 7, the
activity of the IVa2 promoter increased, up to 8.5-fold, as a
function of the quantity of IVa2-RF DNA was also intro-
duced. Furthermore, the Rep6 mutation increased promoter
activity in the presence, but not in the absence, of the
competitor DNA.
The properties of IVa2 transcription in the transient ex-
pression system employed in these experiments are fully
consistent with the hypothesis that transcription from this
adenoviral promoter is governed by the relative concentra-
tions of the promoter and of the cellular repressor that binds
to it. The IVa2 promoter was inactive whenever its intracel-
lular concentrations were limited to those introduced by
DNA-mediated transformation (Figs. 2 and 5; Table 2).
Increased promoter concentration as a result of vector rep-
lication from the SV40 origin (Fig. 5B) increased transcrip-
tion from the wild-type IVa2 promoter (Figs. 4 and 5A;
Tables 1 and 2), as did introduction of competitor DNA
containing the IVa2-RF binding site of the viral promoter
(Fig. 7). A mutant IVa2 promoter containing the Rep6
substitution, which decreases the affinity with which
IVa2-RF binds to DNA (Lin and Flint, 2000), was invari-
ably more active than the wild-type (Fig. 6; Table 3). It is
also clear that HeLa cells contain sufficient IVa2-RF to
block transcription from even the relatively large number of
IVa2 promoter-containing DNA molecules introduced per
cell by DNA-mediated transformation (Fig. 2). This prop-
erty suggests that the absence of IVa2 transcription during
the early phase of the infectious cycle is the result of
binding of IVa2-RF to the IVa2 promoters of all infecting
genomes. On the other hand, the results described here
cannot establish whether increased IVa2 promoter concen-
tration following viral DNA synthesis is sufficient to over-
come IVa2-RF-mediated repression in infected cells, as in
this simplified experimental system, or whether additional,
infected cell-specific parameters are also important. The
Rep6 mutation, and others that reduce the affinity which
IVa2-RF binds to the IVa2 promoter (Lin and Flint, 2000),
have therefore been introduced into the endogenous Ad5
IVa2 promoter, so that this issue can be addressed.
Materials and methods
Cells, plasmids, and DNA-mediated transformation
HeLa and COS-1 cells were maintained in monolayer
cultures in Dulbecco’s modified Eagle’s medium (Gibco-
BRL) supplemented with 10% calf serum and 10% fetal calf
serum (Gemini), respectively.
A SacII Ad2 DNA fragment extending from positions
32 of the IVa2 to position 131 of the ML transcription
units (Fig. 1) was ligated into the multiple cloning site of
SV40 origin-containing plasmid pEGFP-1 (Clontech).
Products with the IVa2 promoter upstream of the EGFP
coding sequence were identified by restriction endonuclease
digestion. A plasmid containing the Rep6 mutant IVa2 pro-
moter (Fig. 1) was constructed in the same manner. Deriv-
atives of these plasmids, which are designated
pWTIVa2EGFP-Ori and pRep6IVa2EGFP- Ori, respec-
tively, with nonfunctional origins of replication were then
isolated: the essential origin binding site for SV40 large
T-antigen was replaced by an unrelated sequence by the
unique site elimination method (Deng and Nicholson,
1992), and the recovery of the mutation was confirmed by
sequencing. Plasmid DNAs were purified from Escherichia
coli by the Qiagen maxiprep protocol and their quality was
checked by electrophoresis in 1% agarose gels cast and run
in TAE.
The vector DNAs were introduced into HeLa or COS-1
Fig. 7. Relief of repression of IVa2 transcription by introduction of
IVa2-RF DNA in trans. The SV40 origin-lacking plasmids containing the
wild-type (wt) or Rep6 IVa2-EGFP reporter genes were introduced into
COS-1 cells with the molar excess concentrations of IVa2-RF DNA indi-
cated, and EGFP autofluorescence was examined 48 h later. The means and
standard deviations of two independent experiments are shown. Higher
concentrations of IVa2-RF DNA led to decreased synthesis of EGFP,
presumably as a result of cytotoxicity.
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cells at 70% confluence by the calcium phosphate copre-
cipitation method (Graham and van der Eb, 1973). Various
concentrations of vector DNAs, 2.5 g internal control
DNAs and 25 g salmon sperm DNA, were mixed prior to
precipitation. Cells were incubated with the precipitates for
10 min at room temperature, and fresh medium was then
added. Following incubation at 37°C, the medium and pre-
cipitate were removed and the cells were washed twice with
phosphate-buffered saline (Gibco-BRL) prewarmed to
37°C, prior to addition of fresh medium. In most experi-
ments, this step was performed 18 h after addition of the
DNA-containing precipitates and was defined as time zero.
Incubation at 37°C was continued for the periods indicated
in the figure legends and tables.
Electrophoretic mobility shift assay for IVa2-RF
Whole-cell extracts were prepared in parallel from ac-
tively growing HeLa and COS-1 cells as described previ-
ously (Chen and Flint, 1992; Leong and Flint, 1984). Pro-
tein concentrations were determined by the method of
Bradford (Bradford, 1976). A synthetic, double-stranded
DNA fragment containing the sequence of the IVa2-RF
binding site of the IVa2 promoter (positions 2 to 35)
was 32P-labeled using [-32P]ATP (3000 Ci/mmol, NEN)
and polynucleotide kinase. Binding of IVa2-RF to this DNA
was examined under the conditions described previously
(Chen et al., 1994). Some binding reactions contained vary-
ing concentrations of unlabeled competitor DNAs with the
wild-type sequence or carrying the Rep6 substitution (Lin
and Flint, 2000). Electrophoresis and autoradiography were
as described (Chen et al., 1994).
Analysis of mRNA
COS-1 cells into which vectors carrying chimeric IVa2-
EGFP genes had been introduced were harvested after var-
ious periods of incubation up to 72 h, where time zero was
defined as described in a previous section. Cells were
washed with ice-cold phosphate-buffered saline (Gibco-
BRL) and cytoplasmic and nuclear fractions were separated
by extraction with NP-40 as described (Kasai et al., 1992).
Total RNA was purified from the cytoplasmic fraction by
digestion with proteinase K and phenol:chloroform extrac-
tion. The IVa2-EGFP mRNA was assayed by extension
from a primer complementary to positions 64 to 89 of
the coding strand of the chimeric transcription unit, as
described previously (Kasai et al., 1992). The specific
primer extension products were quantified using a Molecu-
lar Dynamics PhosphorImager.
Analysis of plasmid DNA concentrations
Low-molecular-mass DNA was purified from the nuclear
fractions described in the previous section by the Hirt pro-
cedure (Finnen et al., 2001; Hirt, 1967). The DNA samples
were linearized by digestion with HindIII, denatured, and
loaded onto nylon membranes as described previously
(Finnen et al., 2001; Hirt, 1967). Membranes were then
hybridized to an internal fragment of the EGFP coding
sequence labeled by the random priming method (Feinberg
and Vogelstein, 1983). Signals were detected by autoradiog-
raphy and quantified using a Molecular Dynamics Phos-
phorImager.
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